These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 9660375)
1. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375 [TBL] [Abstract][Full Text] [Related]
2. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S J Affect Disord; 1999; 52(1-3):121-33. PubMed ID: 10357025 [TBL] [Abstract][Full Text] [Related]
3. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278 [TBL] [Abstract][Full Text] [Related]
4. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group. Prochazka H; Sjögren M; Agren H J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832 [TBL] [Abstract][Full Text] [Related]
5. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies. Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090 [TBL] [Abstract][Full Text] [Related]
6. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Soloff PH; Lynch KG; Moss HB Alcohol Clin Exp Res; 2000 Nov; 24(11):1609-19. PubMed ID: 11104107 [TBL] [Abstract][Full Text] [Related]
7. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434 [TBL] [Abstract][Full Text] [Related]
8. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study. Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122 [TBL] [Abstract][Full Text] [Related]
9. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. O'Keane V; Dinan TG Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948 [TBL] [Abstract][Full Text] [Related]
10. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521 [TBL] [Abstract][Full Text] [Related]
11. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis. Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614 [TBL] [Abstract][Full Text] [Related]
12. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Cleare AJ; Bond AJ Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176 [TBL] [Abstract][Full Text] [Related]
13. Prolactin and cortisol responses to fenfluramine in Parkinson's disease. Kostić VS; Lecić D; Doder M; Marinković J; Filipović S Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070 [TBL] [Abstract][Full Text] [Related]
14. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977 [TBL] [Abstract][Full Text] [Related]
15. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135 [TBL] [Abstract][Full Text] [Related]
16. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects. Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728 [TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release. Young AH; Rue J; Odontiadis J; Cowen PJ Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777 [TBL] [Abstract][Full Text] [Related]
19. The hormonal response to a d-fenfluramine challenge in trained and sedentary men. Strachan AT; Maughan RJ Med Sci Sports Exerc; 1999 Apr; 31(4):547-53. PubMed ID: 10211850 [TBL] [Abstract][Full Text] [Related]